Summary

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.

The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.

The public comment period ends on May 7, after which the FDA may finalize the ban.

  • atzanteol
    link
    fedilink
    English
    arrow-up
    5
    arrow-down
    1
    ·
    7 hours ago

    It won’t even take that - you can sell products that don’t work (airborn, homeopathy, etc.), you just can’t claim that it does. So they’ll slap the standard “this product is not intended to treat, cure, or prevent any disease” disclaimer on it and people will continue to buy it.